These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 10728031)
1. Time to treatment and cost of thrombolysis: a multicenter comparison of tPA and rPA. Seyedroudbari A; Kessler ER; Mooss AN; Wundeman RL; Bala M; Hilleman DE J Thromb Thrombolysis; 2000 Apr; 9(3):303-8. PubMed ID: 10728031 [TBL] [Abstract][Full Text] [Related]
2. Comparison of urokinase, alteplase, and reteplase for catheter-directed thrombolysis of deep venous thrombosis. Grunwald MR; Hofmann LV J Vasc Interv Radiol; 2004 Apr; 15(4):347-52. PubMed ID: 15064337 [TBL] [Abstract][Full Text] [Related]
3. Fibrin specificity and procoagulant effect related to the kallikrein-contact phase system and to plasmin generation with double-bolus reteplase and front-loaded alteplase thrombolysis in acute myocardial infarction. Hoffmeister HM; Kastner C; Szabo S; Beyer ME; Helber U; Kazmaier S; Baumbach A; Wendel HP; Heller W Am J Cardiol; 2000 Aug; 86(3):263-8. PubMed ID: 10922430 [TBL] [Abstract][Full Text] [Related]
4. Patency trials with reteplase (r-PA): what do they tell us? Bode C; Nordt TK; Peter K; Smalling RW; Runge MS; Kübler W Am J Cardiol; 1996 Dec; 78(12A):16-9. PubMed ID: 8990406 [TBL] [Abstract][Full Text] [Related]
6. More rapid, complete, and stable coronary thrombolysis with bolus administration of reteplase compared with alteplase infusion in acute myocardial infarction. RAPID Investigators. Smalling RW; Bode C; Kalbfleisch J; Sen S; Limbourg P; Forycki F; Habib G; Feldman R; Hohnloser S; Seals A Circulation; 1995 Jun; 91(11):2725-32. PubMed ID: 7758177 [TBL] [Abstract][Full Text] [Related]
7. Making a case for the right '-ase' in acute ischemic stroke: alteplase, tenecteplase, and reteplase. Chester KW; Corrigan M; Schoeffler JM; Shah M; Toy F; Purdon B; Dillon GM Expert Opin Drug Saf; 2019 Feb; 18(2):87-96. PubMed ID: 30712409 [TBL] [Abstract][Full Text] [Related]
8. Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction. The RAPID II Investigators. Bode C; Smalling RW; Berg G; Burnett C; Lorch G; Kalbfleisch JM; Chernoff R; Christie LG; Feldman RL; Seals AA; Weaver WD Circulation; 1996 Sep; 94(5):891-8. PubMed ID: 8790022 [TBL] [Abstract][Full Text] [Related]
9. Adverse events of tissue plasminogen activators in acute myocardial infarction patients: a real-world and pharmacovigilance database analysis. Liu F; Yang G; Xie J; Xie P; Zhou F; Yang F; Ma Y; Xu F BMC Cardiovasc Disord; 2024 Aug; 24(1):441. PubMed ID: 39179962 [TBL] [Abstract][Full Text] [Related]
10. Feasibility and timing of prehospital administration of reteplase in patients with acute myocardial infarction. Rosenberg DG; Levin E; Lausell A; Brown A; Gardner J; Perez E; Veenendaal M; Ong YS; Gunn M J Thromb Thrombolysis; 2002 Jun; 13(3):147-53. PubMed ID: 12355031 [TBL] [Abstract][Full Text] [Related]
11. Results of the RAPID 1 and RAPID 2 thrombolytic trials in acute myocardial infarction. Weaver WD Eur Heart J; 1996 Sep; 17 Suppl E():14-20. PubMed ID: 11823998 [TBL] [Abstract][Full Text] [Related]
12. Trial of abciximab with and without low-dose reteplase for acute myocardial infarction. Strategies for Patency Enhancement in the Emergency Department (SPEED) Group. Circulation; 2000 Jun; 101(24):2788-94. PubMed ID: 10859283 [TBL] [Abstract][Full Text] [Related]
13. Randomised, double-blind comparison of reteplase double-bolus administration with streptokinase in acute myocardial infarction (INJECT): trial to investigate equivalence. International Joint Efficacy Comparison of Thrombolytics. Lancet; 1995 Aug; 346(8971):329-36. PubMed ID: 7623530 [TBL] [Abstract][Full Text] [Related]
14. Hemodynamic effects of double bolus reteplase versus alteplase infusion in massive pulmonary embolism. Tebbe U; Graf A; Kamke W; Zahn R; Forycki F; Kratzsch G; Berg G Am Heart J; 1999 Jul; 138(1 Pt 1):39-44. PubMed ID: 10385761 [TBL] [Abstract][Full Text] [Related]
15. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial. Topol EJ; Lancet; 2001 Jun; 357(9272):1905-14. PubMed ID: 11425410 [TBL] [Abstract][Full Text] [Related]
16. A comparison of reteplase with alteplase for acute myocardial infarction. Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III) Investigators N Engl J Med; 1997 Oct; 337(16):1118-23. PubMed ID: 9340503 [TBL] [Abstract][Full Text] [Related]
17. Early thrombolysis for the treatment of acute myocardial infarction: a systematic review and economic evaluation. Boland A; Dundar Y; Bagust A; Haycox A; Hill R; Mujica Mota R; Walley T; Dickson R Health Technol Assess; 2003; 7(15):1-136. PubMed ID: 12773258 [No Abstract] [Full Text] [Related]
18. The role of thrombolytic drugs in the management of myocardial infarction. Comparative clinical trials. Weaver WD Eur Heart J; 1996 Dec; 17 Suppl F():9-15. PubMed ID: 8960443 [TBL] [Abstract][Full Text] [Related]
19. Frequency and clinical outcome of cardiogenic shock during acute myocardial infarction among patients receiving reteplase or alteplase. Results from GUSTO-III. Global Use of Strategies to Open Occluded Coronary Arteries. Hasdai D; Holmes DR; Topol EJ; Berger PB; Criger DA; Hochman JS; Bates ER; Vahanian A; Armstrong PW; Wilcox R; Ohman EM; Califf RM Eur Heart J; 1999 Jan; 20(2):128-35. PubMed ID: 10099909 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of the time saved by prehospital initiation of reteplase for ST-elevation myocardial infarction: results of The Early Retavase-Thrombolysis in Myocardial Infarction (ER-TIMI) 19 trial. Morrow DA; Antman EM; Sayah A; Schuhwerk KC; Giugliano RP; deLemos JA; Waller M; Cohen SA; Rosenberg DG; Cutler SS; McCabe CH; Walls RM; Braunwald E J Am Coll Cardiol; 2002 Jul; 40(1):71-7. PubMed ID: 12103258 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]